{"task_id": "6e4ee895b807565b", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 275/464)", "text": "on this\ndecision\nMANAGEMENT (CONT\u2019D)\n264\nInfluenza\n\n--- Page 286 ---\nAntiviral Agents\nAntiviral agents\nMechanism\nHSV, VZV\nCMV\nInfluenza A\nInfluenza B\nAcyclovir 200\u2013800 mg PO BID\n5x/day; 5\u201310 mg/kg IV q8h\nNucleoside analogues\u2014activated\nby viral thymidine kinase, inhibit viral\nDNA polymerase (vDNAp);\nalso incorporated into viral DNA\nand act as a chain terminator\n++\nValacyclovir 500\u20131000 mg PO\ndaily\u2013TID\n++\nFamciclovir 250\u20131000 mg PO\nBID\n++\nPenciclovir 10 mg/g topically\nq2h x4 days\nApplied topically for treatment of\noral cold sores\n++\nGanciclovir 5 mg/kg IV q12h or\n1000 mg PO TID\n(maintenance)\nNucleoside analogue that inhibits\nviral DNA polymerase\n++\n++\nValganciclovir 900 mg PO\ndaily\u2013BID\n++\n+++\nFoscarnet 90 mg/kg IV q12\u201324h\nPyrophosphate analogue that\ninhibits viral DNA polymerase\n++\n+++\nCidofovir 5 mg/kg IV qweek\nNucleoside analogue that inhibits\nviral DNA polymerase\n++\n+++\nAmantadine 100 mg PO BID\nInhibit M2 Protein (ion channel) of\ninfluenza A, blocking uncoating of virus\ngenome within newly infected cells\n++\nRimantadine 100 mg PO BID\n++\nZanamivir 10 mg INH q12\u201324h\nNeuraminidase Inhibitors. Block release\nof influenza virus from infected cells\n++\n++\nOseltamivir 75 mg PO daily\u2013BID\n++\n++\nFungal Infections\nGENERAL APPROACH\nCLASSIFICATION\nfungal infections can be classi\nfied into three main categories: yeasts, molds (\u2018\u2018fila\nmentous fungi\u2019\u2019), and dimorphic fungi\n\u0002\nYEASTS\ngrow as single cells (via budding) and\ninclude Candida, Malassezia, Rodotorula, Trichosporon\n\u0002\nMOLDS\nthese filamentous fungi grow as hyphae\n(via sexual and asexual reproduction) and include\nAspergillus, zygomycetes, Fusarium, and dematiac\neous (pigmented) fungi. Ubiquitous in the envir\nonment (e.g. soil, decaying vegetation, water, air).\nInfection may cause blood vessel invasion, throm\nbosis, and obstruction. Clinical syndromes include\ncerebral parenchymal infections, pulmonary par\nenchymal infections, hepatosplenic abscesses, and\notitis externa\n\u0002\nDIMORPHIC FUNGI\nexist as both molds and yeasts\nand include Coccidioides, Histoplasma, Blasto\nmyces, and Cryptococcus. At low temperatures,\nfound as multicellular molds (which release spores\nthat are inhaled). In warm temperatures (e.g.\ninside the body), inhaled spores germinate into\nyeasts, which are infectious to the patient, but no\nlonger contagious (i.e. these patients do not\nrequire isolation)\nCANDIDIASIS\nPATHOPHYSIOLOGY\nCandida albicans (\u2018\u2018Germ tube\npositive\u2019 with pseudohyphae) or non albicans species\n(\u2018Germ tube negative,\u2019\u2019 e.g. C. glabrata, C. tropicalis, C.\nparapsilosis, C. krusei), mostly in patients with hemato\nlogical malignancy, neutropenia, on immunosuppres\nsants, IDU, or those in the intensive care unit with\nhemodialysis, broad spectrum antibiotics, surgery,\ncentral venous catheters, and parenteral nutrition\nCLINICAL\nFEATURES\nlocalized\nmucocutaneous\ninfections (thrush and vaginitis), serious focal infec\ntions (endophthalmitis, meningitis, osteomyelitis), or\ndisseminated infection (candidemia) with pustular\nskin lesions, retinal lesions. Candiduria is common in\nICU patients, but represents colonization only unless\npatient is symptomatic\nTREATMENTS\n\u0002\nOROPHARYNGEAL\nclotrimazole troche 10 mg 5\u0005\ndaily, nystatin suspension (500,000 U) or nystatin\npastilles (200,000 U) 4\u0005 daily, fluconazole 100 mg\nPO/IV daily \u00051 2 weeks\n\u0002\nESOPHAGITIS\nfluconazole 200 mg PO/IV daily\n\u00052 3 weeks\n\u0002\nCANDIDURIA\nremove\ncatheter,\nindications\nfor\ntreatment include kidney transplant recipients,\nFungal Infections\n265", "text_length": 3461, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 275/464)", "type": "chunk", "chunk_index": 274, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.624542", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.625250", "status": "complete", "chunks_added": 2}